Nath Bio-Genes (India) share news, announcements and annual reports
NSE: NATHBIOGENBSE: 537291Agricultural Food & other ProductsSmall Cap
Nath Bio-Genes (India) Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 2014
Last close ₹131.01down ₹1.37 (1.03%)BSE ₹131.50
Share price at the NSE close on 30 Oct 2026. Previous close ₹132.38.
30 Oct: open ₹132.05, high ₹135.95, low ₹130.52
52-week range of traded prices to 30 Oct 2026
₹126.15Low, 30 Mar 2026₹204.00High, 30 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹249 Cr2,134th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 6.80
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹7.21 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 8.47
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.37
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.53%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹7.21 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 4.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 5,41466.2% delivered
Nath Bio-Genes (India) share news and announcements
336 announcements, routine notices left out, newest first. Page 6 of 7.
May 2018
31 May · Results
14 May · Updates
Apr 2018
27 Apr · Analysts
6 Apr · Legal
The exchange asked on 5 Apr 2018
Mar 2018
Feb 2018
15 Feb · Legal
Exchange has sought clarification from Nath Bio-Genes (India) Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Reconciliation of profit and loss not submitted. The response of the Company is awaited.14 Feb · Results
Jan 2018
31 Jan · Board meeting
25 Jan · Board meeting
22 Jan · Board meeting
9 Jan · Board meeting
8 Jan · Legal
The exchange asked on 3 Jan 2018
8 Jan · Meeting
5 Jan · Meeting
Dec 2017
12 Dec · Business
8 Dec · Board meeting
Nov 2017
18 Nov · Analysts
2 Nov · Legal
Exchange has sought clarification from Nath Bio-Genes (India) Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not submitted as per Schedule III to the Companies Act, 2013 -2. Financial results not submitted as per Ind-AS format -3. Reconciliation of profit and loss not submitted The response of the Company is awaited.
Oct 2017
28 Oct · Results
11 Oct · Analysts
Sep 2017
29 Sep · Updates
Aug 2017
Jul 2017
31 Jul · Results
14 Jul · Board meeting
Jun 2017
May 2017
30 May · Results
24 May · Updates
Apr 2017
Jan 2017
28 Jan · Results
16 Jan · Board meeting
Nov 2016
14 Nov · Results
Oct 2016
Aug 2016
24 Aug · Analysts
9 Aug · Meeting
4 Aug · Limited Review Report